Pharmacological blocking of VISTA promotes the repolarization of macrophages towards a pro-inflammatory phenotype, increases CD8 + T cell infiltration and activation within the TME, thereby augmenting anti-tumour immunity in TNBC. This evidence concerns the gene CD8A and neoplasm.